Upfront DPYD Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress

SIMPLE SUMMARY: The combination of carboplatin and 5-fluorouracil (5-FU) is effective when used concurrently with radiotherapy for locoregionally advanced oropharyngeal carcinomas. DPYD polymorphisms can be associated with an increased risk of severe toxicity to fluoropyrimidines. Upfront screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Desilets, Antoine, McCarvill, William, Aubin, Francine, Bahig, Houda, Ballivy, Olivier, Charpentier, Danielle, Filion, Édith, Jamal, Rahima, Lambert, Louise, Nguyen-Tan, Phuc Felix, Vadnais, Charles, Weng, Xiaoduan, Soulières, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870563/
https://www.ncbi.nlm.nih.gov/pubmed/35200545
http://dx.doi.org/10.3390/curroncol29020045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870563/
https://www.ncbi.nlm.nih.gov/pubmed/35200545
http://dx.doi.org/10.3390/curroncol29020045

Ejemplares similares